QuidelOrtho Corp

QuidelOrtho Corporation develops and sells diagnostic products. The company leverages its expertise in immunoassay and molecular testing, clinical chemistry, and transfusion medicine to provide diagnostic solutions. QuidelOrtho operates globally, serving customers in over 140 countries and territories. Its manufacturing facilities are located in the U.S., U.K., and China, supported by sales centers, administrative offices, and warehouses worldwide. Products are sold directly through a sales force and through distributors for professional use in various settings, including physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care settings, blood banks, and donor centers. Additionally, products are sold for individual, non-professional, over-the-counter use. The business is managed geographically with reportable segments: North America, EMEA, China, JPAC, and Latin America. Revenue is generated across several business units: Labs, Transfusion Medicine (comprising Immunohematology and Donor Screening product categories), Point of Care, and Molecular Diagnostics. The company also generates non-core revenue from its contract manufacturing business and certain business collaborations.